LEADER 03804nam  2200733   450 
001 9910826711103321
005 20221206183706.0
010   $a1-280-26863-8
010   $a9786610268634
010   $a92-9173-654-6
010   $a1-4237-4294-X
010   $a92-9173-400-4
035   $a(CKB)2550000000038474
035   $a(SSID)ssj0000096448
035   $a(PQKBManifestationID)11515916
035   $a(PQKBTitleCode)TC0000096448
035   $a(PQKBWorkID)10097270
035   $a(PQKB)11142336
035   $a(MiAaPQ)EBC4388523
035   $a(MiAaPQ)EBC284735
035   $a(Au-PeEL)EBL4388523
035   $a(CaPaEBR)ebr10104375
035   $a(OCoLC)62795030
035   $a(Au-PeEL)EBL284735
035   $a(CaONFJC)MIL26863
035   $a(OCoLC)191246240
035   $a(EXLCZ)992550000000038474
100   $a20160215h20052005  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aAccess to treatment in the private-sector workplace /$fthis best practice publication was researched and written by Lindsay Knight
210  1$aGeneva, Switzerland :$cUNAIDS,$d2005.
210  4$dİ2005
215   $a1 online resource (52 pages)
225 1 $aUNAIDS Best Practice Collection
300   $a"A joint publication of the Joint United Nations Programme on HIV/AIDS (UNAIDS), the International Labour Organization (ILO), the World Health Organization (WHO), and the Global Business Coalition on HIV/AIDS."
320   $aIncludes bibliographical references.
327   $aIntro -- Table of contents -- Preface -- 1. Introduction -- 2. Impact of HIV and AIDS on business -- Recognizing that the AIDS epidemic is a workplace issue -- Declining productivity and increasing costs -- Economic growth and development -- 3. The business sector response -- 4. Key components -- 5. Access to treatment in the private-sector workplace: the experience of three South African companies -- 1. ANGLO AMERICAN plc -- How antiretroviral drugs are provided -- Available human resources and capacity-building -- How patients are selected -- Providing and dispensing drugs -- Patient numbers in the antiretroviral therapy programme -- Some results -- Economic evaluation -- 2. BHP BILLITON -- 3. ESKOM -- 6. Conclusion -- Need for antiretroviral therapy -- Providing antiretroviral therapy -- Care and support -- Challenges -- References -- Other resources.
330   $aCompanies cannot ignore HIV; it is a business issue demanding a response now and influencing longer term strategic planning. HIV infection among employees poses a significant threat to operational stability and future profitability. This study outlines how three major companies operating in South Africa have recognized both the challenges HIV poses and their moral duty of care, and have implemented programmes to treat and care for employees and their families.
410  0$aUNAIDS best practice collection.
606   $aHIV infections$xSocial aspects
606   $aAIDS (Disease)$xTreatment
606   $aHealth services accessibility
606   $aAntiretroviral agents
615  0$aHIV infections$xSocial aspects.
615  0$aAIDS (Disease)$xTreatment.
615  0$aHealth services accessibility.
615  0$aAntiretroviral agents.
676   $a362.1969792
700   $aKnight$b Lindsay$01682610
712 02$aJoint United Nations Programme on HIV/AIDS.
712 02$aInternational Labour Organisation.
712 02$aWorld Health Organization.
712 02$aGlobal Business Coalition on HIV/AIDS.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910826711103321
996   $aAccess to treatment in the private-sector workplace$94052865
997   $aUNINA